Remifentanil-propofol vs. sufentanil-propofol: Optimal combinations in clinical anesthesia

Acta Anaesthesiologica Scandinavica

Volumn 47, Issue 1, 2003, Pages 84-89

  Lentschener, Claude ^a   Ghimouz, A ^a   Bonnichon, P ^a   Pepion C ^a   Gomola, A ^a   Ozier, Y ^a  

^a Universite Rene Descartes ^*  (France)

Author keywords

Computer simulation; Drug equipotency; Drug interaction; Intravenous anesthesia; Propofol; Remifentanil; Sufentanil

Indexed keywords

EPHEDRINE; OPIATE AGONIST; PROPOFOL; REMIFENTANIL; SUFENTANIL;

ADULT; AGED; ANESTHESIA INDUCTION; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER SIMULATION; CONCENTRATION (PARAMETERS); CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DRUG DELIVERY SYSTEM; DRUG INFUSION; DRUG POTENCY; DRUG USE; EXTUBATION; FEMALE; HEMODYNAMICS; HUMAN; MALE; PRIORITY JOURNAL; STEADY STATE; THYROID SURGERY; TITRIMETRY;

ADULT; AGED; ANESTHESIA, INTRAVENOUS; ANESTHETICS, INTRAVENOUS; BLOOD PRESSURE; CARBON DIOXIDE; DRUG COMBINATIONS; ELECTROENCEPHALOGRAPHY; FEMALE; HEART RATE; HUMANS; MALE; MIDDLE AGED; PIPERIDINES; PROPOFOL; SUFENTANIL;

EID: 0037225748     PISSN: 00015172     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-6576.2003.470115.x     Document Type: Article

References (21)

1. Glass PSA. Anesthetic drug interactions. Anesthesiology 1998: 88: 5-6.
2. Brunner MD, Braithwaite P, Jhaveri R et al. MAC reduction of isoflurane by sufentanil. Br J Anaesth 1994: 72: 42-46.
3. Katoh T, Ikeda K. The effect of fentanyl on sevoflurane requirements for loss of consciousness and skin incision. Anesthesiology 1998: 88: 18-24.
4. Samra SK, Dy EA, Welch KB, Lovely LK, Graziano GP. Remifentanil- and fentanyl-based anesthesia for intraoperative monitoring of somatosensory evoked potentials. Anesth Analg 2001: 92: 1510-1515.
5. Jhaveri R, Joshi P, Batenhorst R, Baughman V, Glass PSA. Dose comparison of remifentanil and alfentanil for loss of consciousness. Anesthesiology 1997: 87: 253-259.
6. Glass PSA, Iselin-Chaves IA, Goodman D, Delong E, Hermann DJ. Determination of the potency of remifentanil compared with alfentanil using ventilatory depression as the measure of opioid effect. Anesthesiology 1999: 90: 1556-1563.
7. Egan TD, Minto CF, Hermann DJ, Barr J, Muir KT, Shafer SL. Remifentanil versus alfentanil: Comparative pharmacokinetics and pharmacodynamics in healthy adult male volunteers. Anesthesiology 1996: 84: 821-833.
8. Vuyk J, Mertens MJ, Olofsen E, Burm AGL, Bovill JG. Propofol anesthesia and rational opioid selection. Anesthesiology 1997: 87: 1549-1562.
9. Shafer SL, Varvel JR. Pharmacokinetics, pharmacodynamics, and rational opioid selection. Anesthesiology 1991: 74: 53-63.
10. Glass PS, Bloom M, Kearse L, Rosow C, Sebel P, Manberg P. Bispectral analysis measures sedation and memory effects of propofol, midazolam, isoflurane and alfentanil in healthy volunteers. Anesthesiology 1997: 86: 836-847.
11. Liu J, Singh H, White PF. Electroencephalographic bispectral index correlates with intraoperative recall and depth of propofol-induced sedation. Anesth Analg 1997: 84: 185-189.
12. Lang E, Kapila A, Shlugman D, Hoke JF, Sebel PS, Glass PSA. Reduction of isoflurane minimum alveolar concentration by remifentanil. Anesthesiology 1996: 85: 721-728.
13. Kearse LA, Manberg P, Chamoun N, deBros F, Zaslavsky A. Bispectral analysis of the electroencephalogram correlates with patient movement to skin incision during propofol/nitrous oxide anesthesia. Anesthesiology 1994: 81: 1365-1370.
14. Vuyk J. Pharmacokinetic and pharmacodynamic interactions between opioids and propofol. J Clin Anesth 1997: 9: 23S-26S.
15. Chung F, Mulier JP, Scholz J et al. A comparison of anaesthesia using remifentanil combined with either isoflurane, enflurane or propofol in patients undergoing gynaecological laparoscopy, varicose vein or arthroscopic surgery. Acta Anaesthesiol Scand 2000: 44: 790-798.
16. Servin F. Remifentanil: When and how to use it. Eur J Anaesthesiol 1997: 14: 41-44.
17. Ozkose Z, Yalcin Cok O, Tuncer B, Tufekcioglu S, Yardim S. Comparison of hemodynamics, recovery profile, and early postoperative pain control and costs of remifentanil versus alfentanil-based total intravenous anesthesia (TIVA). J Clin Anesth 2002: 14: 161-168.
18. Hoymork SC, Raeder J, Grimsmo B, Steen PA. Bispectral index, predicted and measured drug levels of target-controlled infusions of remifentanil and propofol during laparoscopic cholecystectomy and emergence. Acta Anaesthesiol Scand 2000: 44: 1138-1144.
19. Glass PSA, Shafer SL, Jacobs JR, Reves JG. Intravenous drug delivery systems. In: Miller RD, ed. Anesthesia, 4th Edn. New York: Churchill Livingstone, 1994: 389-416.
20. Rampil IJ, Kim JS, Lenhardt R, Negishi C, Sessler DI. Bispectral EEG index during nitrous oxide administration. Anesthesiology 1998: 89: 671-677.
21. Olmos M, Ballester JA, Vidarte MA, Elizalde JL, Escobar A. The combined effect of age and premedication on the propofol requirements for induction by target-controlled infusion. Anesth Analg 2000: 90: 1157-1161.